tiprankstipranks
Advertisement
Advertisement
Telix Grants Share Appreciation Rights to Director David Gill
PremiumCompany AnnouncementsTelix Grants Share Appreciation Rights to Director David Gill
17h ago
Analyst Reiterates Buy on Telix Pharmaceuticals, Sees 38–42% Upside with Unchanged $22.4 Price Target
Premium
Ratings
Analyst Reiterates Buy on Telix Pharmaceuticals, Sees 38–42% Upside with Unchanged $22.4 Price Target
7d ago
Telix Shareholders Back All Resolutions at Annual General Meeting
Premium
Company Announcements
Telix Shareholders Back All Resolutions at Annual General Meeting
11d ago
Challenger exits substantial holder position in Telix Pharmaceuticals
PremiumCompany AnnouncementsChallenger exits substantial holder position in Telix Pharmaceuticals
27d ago
Telix to Release Escrowed Shares from Lightpoint Acquisition
Premium
Company Announcements
Telix to Release Escrowed Shares from Lightpoint Acquisition
1M ago
Telix to Spotlight Next‑Generation PSMA Therapy Portfolio in Investor Webinar
Premium
Company Announcements
Telix to Spotlight Next‑Generation PSMA Therapy Portfolio in Investor Webinar
1M ago
Telix Issues New Unquoted Share Rights Under Employee Incentive Scheme
PremiumCompany AnnouncementsTelix Issues New Unquoted Share Rights Under Employee Incentive Scheme
2M ago
Telix Reports Lapse of Share Appreciation and Performance Rights
Premium
Company Announcements
Telix Reports Lapse of Share Appreciation and Performance Rights
2M ago
Telix Pharmaceuticals Files Appendix 3B for Proposed Securities Issue
Premium
Company Announcements
Telix Pharmaceuticals Files Appendix 3B for Proposed Securities Issue
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100